Search

everythinglearnresearchcommunity

for

Search:↓

Activating STAT5 in the skin's dermal papilla is key for starting hair growth, regenerating hair follicles, and healing wounds.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

The enzyme CD73 helps control human hair growth and could be targeted to treat hair growth disorders.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Human hair follicles have a scent receptor that can influence hair growth.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Finasteride caused a rare skin rash in a man, which improved after stopping the medication.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Early and aggressive treatment can significantly regrow hair in discoid lupus erythematosus.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

A woman with both TLE and SLE improved with hydroxychloroquine treatment.

A man got a rare rash from the drug topiramate, which went away after he stopped taking it.

ILC1 cells contribute to hair loss in alopecia areata.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Fat tissue-derived cells show promise for repairing body tissues, but more research and regulation are needed for safe use.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.